Vaccinate your immunocompromised patients!

Rheumatology

Volumn 45, Issue 1, 2006, Pages 9-10

  Glück, Thomas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; EDITORIAL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; LYMPHOCYTOPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; VACCINATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; OPPORTUNISTIC INFECTIONS; VACCINATION;

EID: 29844444036     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei237     Document Type: Editorial

References (21)

1. Doran MF, Crowson CS, Pond GR, O'Fallon M, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls. A population based study. Arthritis Rheum 202;46:2287-93.
2. Glück T, Geerdes-Fenge HF, Straub RH, Raffenberg M, Lang B, Lode H, Schölmerich J. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 2000; 28:227-30.
3. Glück T, Kiefmann B, Grohmann M, Falk W, Straub RH, Schölmerich J. Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 2005; 32:1473-80.
4. Centers for Disease Control and prevention. Recommended adult immunization schedule - United States, October 2004 - September 2005. MMWR 2004;53:Q1-Q4. Available at http://www.cdc.gov/nip/recs/ adult-schedule.htm
5. STIKO. Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiol Bull 2005:353-64. Available at http://www.rki.de
6. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Influence of methotrexate, TNF-blockers and prednisolone on antibody responses to pneumococcal vaccine in patients with rheumatoid arthritis. Rheumatology 2005 Nov 15 [Epub ahead of print].
7. Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ, Whitmore JB. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-61.
8. de Roux A, Schmidt N, Rose M, Zielen S, Pletz M, Lode H. Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. Respir Med 2004;98:1187-94.
9. Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, Kolstad A. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 2002;19:71-8.
10. Glaser R, Sheridan J, Malarkey WB, MacCallum RC, Kiecolt-Glaser JK. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 2000; 62:804-7.
11. Dengler TJ, Strnad N, Buhring I et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998;66:1340-7.
12. Avery RK. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 1999;25:567-84.
13. Cornu C, Yzebe D, Leophonte P, Gaillat J, Boissel JP, Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: A meta-analysis of randomized trials. Vaccine 2001;19:4780-90.
14. Posfay-Barbe KM, Wald ER. Pneumococcal vaccines: Do they prevent infection and how? Curr Opin Infect Dis 2004;17:177-84.
15. Jackson LA, Neuzil KM, Yu O et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348:1747-75.
16. Herron A, Dettleff G, Hixon B et al. Influenza vaccination in patients with rheumatic diseases: Safety and efficacy. JAMA 1979;242:53-6
17. Chalmers A, Scheifele D, Patterson C et al. Immunization of patients with rheumatoid arthritis against influenza: A study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203-6.
18. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski M. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
19. Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT. Pharmacoeconomics of influenza vaccination for healthy working adults: Reviewing the available evidence. Drugs 2002;62:1013-24.
20. Ovsyannikova IG, Jacobson RM, Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics 2004;5:417-27.
21. Centers for Disease Control and Prevention. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: A report on recommendations of the Task Force on Community Preventive Services. MMWR 2005;54(No. RR-5).